疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

. P( h; r) \3 _, o# I" x: o$ CApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
# d" M, K1 k8 j( M
( W3 W1 n2 B& }- F1 Q$ @* ~, zhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
0 a' E$ V' x% V
/ q0 }$ n7 N: S0 k9 aSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
9 o5 n! R2 t4 {' c0 U9 W2 Vaccine immunology 14
  V# r, ]' Z$ r/ y$ {3 The vaccine industry 33
4 Vaccine manufacturing 44
" Z. C* V4 e& a! v; q: L5 Evolution of adjuvants across the centuries 58
3 }$ }6 C: S/ w, I' U! Z6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
: I6 ?# o5 e$ Y) x% d1 S8 General immunization practices 88
& B& A' {- B) @SECTION 2: Licensed vaccines
5 _, i/ E8 b8 C( {8 B9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
7 `/ M6 r! n# y7 U4 A. t% x12 Diphtheria toxoid 153
( G, C4 C; m7 K& u$ r13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
% u# @9 k3 {4 c# e  [15 Hepatitis B vaccines 205
8 J8 O% m) |8 @. K* j6 r& `5 b16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
- q) Q+ d( M! i* V18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
& T4 S5 R& D6 P3 n7 s1 Y' {( \20 Measles vaccines 352
4 f0 y6 ^. k# ]5 M; p& J; O21 Meningococcal vaccines 388
22 Mumps vaccine 419
) E. B( d) V8 P# j" X/ e8 j23 Pertussis vaccines . 447
8 t* h: a  ^. L24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
0 Q# O. X4 v" ^& D& o( y. C34 Tick-borne encephalitis virus vaccines 773
  a/ u6 T! v  d35 Tuberculosis vaccines 789
/ G/ [6 X) O7 A36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
4 k3 }, j1 Q, E39 Zoster vaccine 969
$ C9 m( s& y8 o: ?: s2 n3 n40 Combination vaccines 981
. U' g% h0 {/ e. F  Z5 BSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
5 v* t3 f$ `" x$ Z; t44 Dengue vaccines 1042
4 d# W1 ~, x4 P; ^+ G" x6 t45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
$ X+ }4 I, E5 M  W7 _! X+ f6 P, ]49 Hepatitis E vaccines 1085
6 E- m  `, ~3 |/ c, n50 Herpes simplex virus vaccines 1090
5 ]/ q7 H5 b& R/ O5 ^6 H/ E51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
6 L% V5 p) C+ U! b' q  w53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
8 H4 o5 h! g* M. W8 U: V! N60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
2 {: M; g5 T# B. d- C% X; R64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
6 c  U' Y" d  i  [5 ^" V0 R) ?0 K66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
: i" a8 W$ N: U2 n# K$ b" ^67 Immunization in the United States 1310
2 ]; i1 q9 |( T9 j68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
. U8 n# e7 \7 ]4 C73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
- \' s4 K7 ~  ~- Q8 V; L75 Regulation of vaccines in developing countries 1454
7 V+ B9 k3 y9 E. h9 C76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508



8 g5 _% g7 |% G

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

, p; ^" X0 l' i9 P, [) i, @Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

  B. b& u* s3 Qhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
- u2 W1 k6 \9 f$ G6 t2 I
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
% z! @8 E5 p) \5 ]- G9 e# i! E3 The vaccine industry 33
1 G/ f+ e2 U* z/ u4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
3 f- M" L: \( Q: ?3 @0 U6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
4 t2 x7 n1 b6 U5 U8 General immunization practices 88
, K* m, Z8 U& y2 d' Y7 D( uSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
7 N% v; I5 w* y  q  W11 Cholera vaccines 141
12 Diphtheria toxoid 153
( L3 E' H; _; l8 J, H13 Haemophilus influenzae vaccines 167
# U) r4 X6 U" {) X9 [, L' I  O) P14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
2 k- u* [, T! b/ ?8 _0 K# `17 Inactivated influenza vaccines 257
5 S% D1 {2 Y( ~/ D% f18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
( t( X8 z# d; W4 r. @* ]" z22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
1 I! [" x3 U4 h* i3 F; F28 Poliovirus vaccine-live 598
, t+ j: t+ b' R- Y: ?0 J$ ]! z/ E29 Rabies vaccines .646
30 Rotavirus vaccines . 669
. z) r* Z* t, y% v- l$ k% n3 X31 Rubella vaccine 688
. a6 i* j: r. o1 r4 k5 H32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
  W' w2 G8 @% e0 h0 a: b, m35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
' v% p/ x+ [4 b0 ]1 H37 Varicella vaccine 837
38 Yellow fever vaccine 870
0 U. w" Q, q" E) ^. r$ H1 I( A39 Zoster vaccine 969
40 Combination vaccines 981
# ?% g7 G! A2 n& U/ p" mSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
: G( b& x& ?  h& F7 q# g  J% H46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
* s0 E( a4 R6 s48 Hepatitis C vaccines 1074
6 Y8 D! v- J' e, F7 s49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
( J1 k: Z: h9 S  u52 Lyme disease vaccines 1122
2 Z6 v4 Y$ I+ y; d53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
9 L0 H+ D2 M, j9 h# t0 r55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
1 O6 N- @7 n3 w" Z57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
# }, b2 [" l, C7 h, Y. K9 z  ^59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
' Q1 S! i6 h1 F0 n: f61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
$ e/ K- k1 e) y5 D0 \0 }9 i63 Vaccination of immunocompromised hosts 1243
: J2 |7 U0 C9 @64 Vaccination of human immunodeficiency virus-infected persons 1257
" r- u5 o9 m$ V, ?: T7 [. k5 z& B2 {65 Vaccines for international travel 1270
0 r; ]/ Z; E) i0 x6 b66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
# w3 I2 A/ a! ^# d+ P3 f, S67 Immunization in the United States 1310
, [- m! y8 X; i, m68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
7 b: q8 l* U9 W0 f8 @9 ^/ W72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
1 j4 E; W/ ?' Q; C3 T, u0 v74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
0 ?. N$ s/ p) o/ g9 V6 ?: W76 Vaccine safety 1464
77 Legal issues . 1481
4 s0 m3 Y) C- x( \3 p! j78 Ethics 1508
0 E; _+ `  {, T& A  T
9 J' u; N, |5 d) y( ?
5 {, Z) @+ v6 H9 D0 f% h

casarett

Vaccines, 6e, 2012
: Z. t- j) ~2 Q& }9 W4 ?0 l8 B* S
Hardcover: 1570 pages
7 K$ P3 ]2 k/ B9 ?: x0 hPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)
8 _1 H4 }6 s- R4 x& Y' F
2013 BMA Medical Book Awards Highly Commended in Public Health!
1 G" F' x2 U. z  LApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

) Y! k/ t: Q9 J2 I7 ^! O2 a" i1 oGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
) n( C/ M3 {0 SGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
9 [: }" U" K9 K. e( h' ]! nAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
( H7 y* R( z6 r; p8 f! A* x( LClearly visualize concepts and objective data through an abundance of tables and figures.
  f9 ^' C- b# x, e, G' `Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
/ W/ O0 _7 u/ m4 M3 ]: k. G; [+ gMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
+ ?* B3 M- [  y" R& l# w+ ^7 @Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
! ?- E2 u; w; r7 T
( v* q, _; D9 L( h  ^Download link: http://pan.baidu.com/s/1i5NxwLR
) G( ?, y( ?4 V2 X- T& |7 CCode for downloading: dv96